Retinal pigment epithelium tear after intravitreal bevacizumab injection for polypoidal choroidal vasculopathy.
Peng
C-H
CH
Cheng
C-K
CK
Chiou
S-H
SH
D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002829:Choroid / Q000098:blood supply*; D015862:Choroid Diseases / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012167:Retinal Perforations / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D041623:Tomography, Optical Coherence
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab